Atlas Trials

A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes

Clinical trial NCT04855292 · COMPLETED

Trial details

NCT number
NCT04855292
Sponsor
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes
Start date
2021-07-01
Primary completion
2022-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.